WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002030941) TOPOISOMERASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/030941    International Application No.:    PCT/US2001/030640
Publication Date: 18.04.2002 International Filing Date: 01.10.2001
Chapter 2 Demand Filed:    03.05.2002    
IPC:
C07H 9/06 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY [US/US]; P.O. Box 4000, Route 206 and Provinceline Road, Princeton, NJ 08543-4000 (US) (For All Designated States Except US).
SAULNIER, Mark, G. [US/US]; (US) (For US Only).
RUEDIGER, Edward, H. [CA/CA]; (CA) (For US Only).
BALASUBRAMANIAN, Neekakantan [US/US]; (US) (For US Only).
MAHLER, Mikael [CA/CA]; (CA) (For US Only).
BEAULIEU, Francis [CA/CA]; (CA) (For US Only).
BACHAND, Carol [CA/CA]; (CA) (For US Only).
FRENNESSON, David, B. [US/US]; (US) (For US Only)
Inventors: SAULNIER, Mark, G.; (US).
RUEDIGER, Edward, H.; (CA).
BALASUBRAMANIAN, Neekakantan; (US).
MAHLER, Mikael; (CA).
BEAULIEU, Francis; (CA).
BACHAND, Carol; (CA).
FRENNESSON, David, B.; (US)
Agent: PEIST, Kenneth; Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543-4000 (US)
Priority Data:
60/238,726 06.10.2000 US
Title (EN) TOPOISOMERASE INHIBITORS
(FR) INHIBITEURS DES TOPO-ISOMERASES
Abstract: front page image
(EN)The present invention relates to novel N12, N13-bridged sugar derivatives of indolylopyrrolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor cells.
(FR)L'invention concerne des nouveaux dérivés glycosides, pontés en N12, N13, d'indolylopyrrolocarbazoles; elle concerne également des formulations pharmaceutiques de ces dérivés, lesquelles possèdent une activité à l'égard des topo-isomérases-I et sont donc utiles pour inhiber la prolifération de cellules tumorales.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)